Add to ORKGTerazosin treatment suppresses basic fibroblast growth factor expression in the rat ventral prostate Article in Clinical and investigative medicine. Medecine clinique et experimentale · February 200
Cryocompression therapy after elective arthroplasty of the hip Article in Hip international: the j...
Drug costs in the management of metastatic castration-resistant prostate cancer in Canad
Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients: cl...
Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expan...
Exploring patient demographic and clinical characteristics associated with lipid-lowering pharmacoth...
Development and pilot‐testing of a Decision Aid for use among Chinese women facing breast cancer sur...
Prostate-specific antigen kinetic profiles during androgen deprivation therapy as prognostic factors...
Transforming growth factor-β signaling at the tumor-bone interface promotes mammary tumor growth and...
Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected ...
Treatment of chronic pain by using intrathecal drug therapy compared with conventional pain therapie...
Specific biomarkers of receptors, pathways of inhibition and targeted therapies: Clinical applicat...
A focus on the preclinical development and clinical status of the histone deacetylase inhibitor, ro...
Improving the quality of pretreatment staging in patients with esophageal carcinoma- a fast track st...
antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a..
Objective. To study the effects of an α1-adrenoceptor antagonist, terazosin on the androgen-independ...
Cryocompression therapy after elective arthroplasty of the hip Article in Hip international: the j...
Drug costs in the management of metastatic castration-resistant prostate cancer in Canad
Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients: cl...
Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expan...
Exploring patient demographic and clinical characteristics associated with lipid-lowering pharmacoth...
Development and pilot‐testing of a Decision Aid for use among Chinese women facing breast cancer sur...
Prostate-specific antigen kinetic profiles during androgen deprivation therapy as prognostic factors...
Transforming growth factor-β signaling at the tumor-bone interface promotes mammary tumor growth and...
Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected ...
Treatment of chronic pain by using intrathecal drug therapy compared with conventional pain therapie...
Specific biomarkers of receptors, pathways of inhibition and targeted therapies: Clinical applicat...
A focus on the preclinical development and clinical status of the histone deacetylase inhibitor, ro...
Improving the quality of pretreatment staging in patients with esophageal carcinoma- a fast track st...
antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a..
Objective. To study the effects of an α1-adrenoceptor antagonist, terazosin on the androgen-independ...
Cryocompression therapy after elective arthroplasty of the hip Article in Hip international: the j...
Drug costs in the management of metastatic castration-resistant prostate cancer in Canad
Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients: cl...